By Chris Kaiser, Cardiology Editor, MedPage Today LOS ANGELES — A prolonged and strenuous randomized hearing found a slight advantage for chelation therapy in post-myocardial infarction patients, though researchers cautioned that a argumentative therapy is not prepared for prime-time. In 1,708 patients followed for an normal of 4 years, those receiving chelation therapy had fewer combination events compared with remedy — 26% contra 30% (HR 0.82, 95% CI 0.69 to 0.99, P=0.035), reported Gervasio Lamas, MD, of Mount Sinai Medical Center in Miami Beach, Fla. But in a apart substudy, there were no poignant differences in patients’ peculiarity of life, according to Daniel Mark, MD, MPH, from Duke University Medical Center in Durham, N.C., and colleagues. Both late-breaking clinical trials were reported here during the Read full article: http://www.theaustralian.com.au/national-affairs/experts-cane-tony-abbotts-red-tape-cuts-plan/story-fn59niix-1226509179836
Source:
http://www.news.ezonearticle.com/2012/11/04/aha-chelation-tx-in-post-mi-not-ready-yet/
AHA: Chelation Tx in Post-MI Not Ready Yet
Written By Unknown on Sunday, 4 November 2012 | 18:41
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment